Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson and Genmab's blockbuster Darzalex, but now has a chance to steal some of the spotlight. The FDA has ...

Sanofi’s anti-CD38 antibody Sarclisa has struggled to make headway against Genmab and Johnson & Johnson’s rival Darzalex since it was first approved for multiple myeloma, but new data from the ...

Isatuximab is under clinical development by Sanofi and currently in Phase II for Metastatic Colorectal Cancer.

Monoclonal Antibodies IndustryThe global monoclonal antibodies (mAbs) industry, valued at USD 186 billion in 2021, is ...

INR:1282. cricbuzz hindi news Sanofi's Sarclisa for the treatment of multiple myeloma has been supported by NICE for clinical use but has not yet been approve ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Gaza’s health ministry said that 88 people had been killed over the past day. Israeli and Hamas officials have been holding indirect cease-fire talks via mediators in Qatar. By Hiba Yazbek and ...

Russia and other hostile states have become increasingly brazen in adopting “gray zone” attacks against Europe and the United States, leaving defense officials with a dilemma: How to respond ...

Dec. 20, 2024 — Combining bioinformatics and experimetal approaches, researchers have discovered replication hubs for human norovirus, the leading cause of viral gastroenteritis accounting for ...

Dec. 30, 2024 — A new species of black, slender moray eel has chosen the road less traveled, thriving in dim and muddy river mouths, unlike most of its marine ... Six New Tree Species Named: 3 ...

A Brazilian influencer whose staggering 32-stone weight loss made him the star of a reality TV show has died aged 37 after piling on the pounds again following the loss of his dad and brother ...